Cargando…
The role of EZH2 in tumour progression
Accumulated evidence shows that EZH2 is deregulated in a wide range of cancer types, and it has a crucial role in stem cell maintenance and tumour development. Therefore, blocking EZH2 expression or activity may represent a promising strategy for anticancer treatment. In this review, we address the...
Autores principales: | Chang, C-J, Hung, M-C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261672/ https://www.ncbi.nlm.nih.gov/pubmed/22187039 http://dx.doi.org/10.1038/bjc.2011.551 |
Ejemplares similares
-
Role of osteopontin in tumour progression
por: Rittling, S R, et al.
Publicado: (2004) -
The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression
por: Houthuijzen, J M, et al.
Publicado: (2012) -
The metastasis associated protein S100A4: role in tumour progression and metastasis
por: Helfman, D M, et al.
Publicado: (2005) -
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
por: Ciarapica, Roberta, et al.
Publicado: (2011) -
The role of the VEGF-C/VEGFR-3 axis in cancer progression
por: Su, J-L, et al.
Publicado: (2007)